2020.07.07 - admin2 Over 2,500 m2 of research and infrastructure space, worth nearly PLN 117 million, is being built in the nuclear center in Świerk. The investment is carried out as part of a project co-financed by the European Union called Centrum Projektowania i Synetezy Radiofarmaceutyków Ukierunkowanych Molekularnie – CERAD (Design and synthesis of molecularly targeted radiopharmaceuticals – Centrum CERAD).
Professor Renata Mikołajczak became the chairwoman of the working group of the European Pharmacopoeia Commission.
2020.06.19 - Marek Pawłowski The European Pharmacopoeia (Ph. Eur.) is a compact reference document for the quality control of medicines. Its official standards include a specific and legal basis for quality control throughout the entire product life cycle. Ms. Renata Mikołajczak will lead a working group on the development of monographs on radiopharmaceutical precursors (Precursors for Radiopharmaceutical Preparations – PRP Working Party). She is the first person from Poland to whom the European Pharmacopoeia Commission has entrusted such a responsible role.